Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
biospeculator
biospeculator Mar. 16 at 12:47 PM
$RADX There are multiple companies close to treating Her2 and the one I have been watching is GLSI with a market cap of 380M. From what I have determined is they have the one drug and will use it for two different indications. They just ordered up to 1M doses and phase III approval is imminent. However, concerning is that they have yet to be acquired and appear to be going it alone. I have no position but post this so that we are aware of the competition and valuations in the space. GLTA
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 3:23 PM
Radiopharmaceutical buyouts and Market Caps $RADX $IMNM $PYXS $CELC
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 3:07 PM
B7-H3 https://www.linkedin.com/pulse/b7-h3-antibody-market-segmentation-size-trends-2026-2033-4agzf?utm_source=share&utm_medium=member_ios&utm_campaign=share_via $RADX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 2:11 AM
RAD 101 Demonstrates Positive Results in Brain Metastases | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways $RADX https://www.targetedonc.com/view/rad-101-demonstrates-positive-results-in-brain-metastases
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 10:03 PM
Positive sign $18.9 million available on ATM. I thought for a minute because stock was locked in they been issuing stock. However, I looked at the ATM filing and it says $18.9 million available to issue. That tells me they (the company) expects good news. $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 2:54 PM
Big opportunity in HER2 at $RADX (Radiopharm Theranostics) $CELC $SMMT $PBYI
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 2:36 PM
A Look At Celcuity (CELC) Valuation After Priority FDA Review And Strong VIKTORIA 1 Trial Results - Simply Wall St (5.5 billion market cap for her2 drug imagine if RAD202 hits) $RADX https://stocks.apple.com/AcbDmVyXiSIaXxs24TbuOQg
0 · Reply
ChopSeeker
ChopSeeker Mar. 14 at 5:45 AM
$RADX small cap ticker occasionally appearing on scanners
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 2:56 AM
$RADX Huge Pipeline of high value beta Radiopharmaceutical’s https://radiopharmtheranostics.com/wp-content/uploads/2026/03/RAD-Presentation-March-2026.pdf $IOVA $IBRX $VNDA $OPK
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 7:30 PM
Rad101 trial was 50% enrolled on Nov 17th. I am betting they are done enrolling on March 17th which is Tuesday. That’s easily achievable in 5 centers for 15 more. $RADX
0 · Reply
Latest News on RADX
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Wed, 28 Jan 2026 07:00:00 -0500 - 6 weeks ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Mon, 12 Jan 2026 07:00:00 -0500 - 2 months ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Mon, 15 Dec 2025 11:59:59 -0500 - 3 months ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Mon, 15 Dec 2025 07:00:00 -0500 - 3 months ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

2025-11-26T18:34:17.000Z - 3 months ago

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

2025-10-20T13:30:38.000Z - 5 months ago

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Mon, 20 Oct 2025 07:30:00 -0400 - 5 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Regal-backed biotech Radiopharm Theranostics launches $35m placement

2025-10-15T23:01:20.000Z - 5 months ago

Regal-backed biotech Radiopharm Theranostics launches $35m placement

Radiopharm Theranostics Limited - Special Call

2025-09-02T05:15:35.000Z - 6 months ago

Radiopharm Theranostics Limited - Special Call

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Tue, 29 Jul 2025 07:30:00 -0400 - 8 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tue, 22 Jul 2025 08:00:00 -0400 - 8 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Mon, 02 Jun 2025 08:00:00 -0400 - 10 months ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon, 19 May 2025 08:00:00 -0400 - 10 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting

2025-03-27T19:13:09.000Z - 1 year ago

Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

2025-03-12T16:57:48.000Z - 1 year ago

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Mon, 30 Dec 2024 08:00:00 -0500 - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Fri, 20 Dec 2024 08:00:00 -0500 - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Thu, 19 Sep 2024 12:00:00 -0400 - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

biospeculator
biospeculator Mar. 16 at 12:47 PM
$RADX There are multiple companies close to treating Her2 and the one I have been watching is GLSI with a market cap of 380M. From what I have determined is they have the one drug and will use it for two different indications. They just ordered up to 1M doses and phase III approval is imminent. However, concerning is that they have yet to be acquired and appear to be going it alone. I have no position but post this so that we are aware of the competition and valuations in the space. GLTA
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 3:23 PM
Radiopharmaceutical buyouts and Market Caps $RADX $IMNM $PYXS $CELC
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 3:07 PM
B7-H3 https://www.linkedin.com/pulse/b7-h3-antibody-market-segmentation-size-trends-2026-2033-4agzf?utm_source=share&utm_medium=member_ios&utm_campaign=share_via $RADX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 15 at 2:11 AM
RAD 101 Demonstrates Positive Results in Brain Metastases | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways $RADX https://www.targetedonc.com/view/rad-101-demonstrates-positive-results-in-brain-metastases
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 10:03 PM
Positive sign $18.9 million available on ATM. I thought for a minute because stock was locked in they been issuing stock. However, I looked at the ATM filing and it says $18.9 million available to issue. That tells me they (the company) expects good news. $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 2:54 PM
Big opportunity in HER2 at $RADX (Radiopharm Theranostics) $CELC $SMMT $PBYI
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 2:36 PM
A Look At Celcuity (CELC) Valuation After Priority FDA Review And Strong VIKTORIA 1 Trial Results - Simply Wall St (5.5 billion market cap for her2 drug imagine if RAD202 hits) $RADX https://stocks.apple.com/AcbDmVyXiSIaXxs24TbuOQg
0 · Reply
ChopSeeker
ChopSeeker Mar. 14 at 5:45 AM
$RADX small cap ticker occasionally appearing on scanners
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 14 at 2:56 AM
$RADX Huge Pipeline of high value beta Radiopharmaceutical’s https://radiopharmtheranostics.com/wp-content/uploads/2026/03/RAD-Presentation-March-2026.pdf $IOVA $IBRX $VNDA $OPK
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 7:30 PM
Rad101 trial was 50% enrolled on Nov 17th. I am betting they are done enrolling on March 17th which is Tuesday. That’s easily achievable in 5 centers for 15 more. $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 4:43 PM
Diamond in the Rough $RADX $PYXS $IMNM $SMMT $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 4:32 PM
Clarity = $1 billion mkt cap $RADX $CATX $MOLN $ATNM $CLRB
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 1:50 PM
$RADX If this goes to a reasonable valuation of $300 million we are talking $25 per share. At $60 million this can go up 5x on good final rad101 data. That doesn’t even count all rhe hot Radiopharmaceutical’s they have that could push it up to $50-100… the B7-H3 asset is super hot big pharma are aggressively pursuing this class.
0 · Reply
no_more_fake_news
no_more_fake_news Mar. 13 at 1:46 PM
$RADX Tough seeing so much green while this one's flat. Could pop any day though
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 1:20 PM
$LLY $NVS $RADX $LNTH $AKTS RADX only value play
0 · Reply
watchaddict
watchaddict Mar. 13 at 11:57 AM
$RADX adding
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 3:20 AM
It’s possible RAD101 could be a $1 to $1.5 billion dollar brain imaging tracer. If it becomes the gold standard. Brain tumors in general live off fatty acids. Therefore that’s why it finds them and lights them up. But radiologist could potentially use it before stereotactic radiation because mri’s don’t always pick up very small brain Mets and definitely after stereotactic radiation because standard mri’s don’t work well after necrosis cause by the radiation laser (gamma or cyber knife). What’s interesting phase2a 10/10 and phase 2b 11/12. Also, there’s a major market for this in European and Asia as well. $RADX $LNTH $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 1:24 AM
B7-H3: A Promising New Target in Tumor Immunotherapy - YouTube $RADX https://www.youtube.com/watch?v=9E6cka7ztSw
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 13 at 12:18 AM
The underlying stock can easily yo to 10 and that would put us around $25.00 per share for the Nasdaq ADR. $RADX
0 · Reply
Lalalilala
Lalalilala Mar. 12 at 5:40 PM
$RADX Hello to all my followers... I currently have 8,000 stocks in my portfolio, all below $5, so I've reached my goal. I'm going to try to acquire another 4,000 to 6,000 below $5. I want to be fully invested before the end of April.
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 12 at 2:56 PM
HSBC new holder just bought 192,000 shares $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 12 at 2:38 PM
$RADX Volume dried up to nothing day before it launched to $24… only 800 shares.. Harley any volume now
1 · Reply